INBIOGEN Past Earnings Performance
Past criteria checks 0/6
INBIOGEN's earnings have been declining at an average annual rate of -41.4%, while the Luxury industry saw earnings growing at 21.6% annually. Revenues have been growing at an average rate of 12.1% per year.
Key information
-41.4%
Earnings growth rate
-33.2%
EPS growth rate
| Luxury Industry Growth | 21.6% |
| Revenue growth rate | 12.1% |
| Return on equity | -41.1% |
| Net Margin | -541.6% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How INBIOGEN makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 10,578 | -57,296 | 7,420 | 3 |
| 31 Dec 22 | 11,404 | -119,687 | 6,904 | 4 |
| 30 Sep 22 | 12,796 | -17,540 | 7,925 | 6 |
| 30 Jun 22 | 12,585 | -25,663 | 8,129 | 23 |
| 31 Mar 22 | 11,698 | 4,306 | 8,321 | 26 |
| 31 Dec 21 | 10,481 | 94,125 | 8,700 | 25 |
| 30 Sep 21 | 9,029 | -55,106 | 7,531 | 22 |
| 30 Jun 21 | 9,965 | -45,421 | 6,887 | 5 |
| 31 Mar 21 | 10,518 | -2,190 | 6,044 | 0 |
| 31 Dec 20 | 10,218 | -45,078 | 5,492 | 0 |
| 30 Sep 20 | 10,384 | -20,751 | 4,264 | 0 |
| 30 Jun 20 | 11,256 | 103 | 3,830 | 0 |
| 31 Mar 20 | 10,521 | 12,217 | 3,285 | 0 |
| 31 Dec 19 | 9,795 | 13,124 | 2,393 | 0 |
| 30 Sep 19 | 8,873 | 19,966 | 2,189 | 0 |
| 30 Jun 19 | 6,753 | 7,368 | -446 | 0 |
| 31 Mar 19 | 6,345 | 1,536 | -663 | 0 |
| 31 Dec 18 | 7,566 | 1,664 | -790 | 0 |
| 30 Sep 18 | 6,836 | 2,060 | -704 | 0 |
| 30 Jun 18 | 6,665 | -827 | 1,381 | 0 |
| 31 Mar 18 | 5,999 | -1,132 | 1,744 | 0 |
| 31 Dec 17 | 7,077 | -1,211 | 1,883 | 0 |
| 30 Sep 17 | 8,347 | -1,518 | 2,477 | 0 |
| 30 Jun 17 | 8,134 | -1,917 | 2,578 | 0 |
| 31 Mar 17 | 9,678 | -2,037 | 2,649 | 0 |
| 31 Dec 16 | 11,545 | -2,256 | 3,207 | 0 |
| 30 Sep 16 | 11,970 | -2,368 | 2,398 | 0 |
| 30 Jun 16 | 11,436 | -5,554 | 5,092 | 0 |
| 31 Mar 16 | 10,064 | -5,617 | 4,760 | 0 |
| 31 Dec 15 | 8,865 | -5,686 | 4,540 | 0 |
| 30 Sep 15 | 8,862 | -5,003 | 4,750 | 21 |
| 30 Jun 15 | 10,955 | -4,357 | 5,078 | 1 |
| 31 Mar 15 | 11,674 | -1,717 | 2,739 | 21 |
| 31 Dec 14 | 11,762 | -1,612 | 2,794 | 21 |
| 30 Sep 14 | 11,413 | -2,004 | 2,994 | 9 |
| 30 Jun 14 | 9,648 | -2,051 | 3,041 | 20 |
| 31 Mar 14 | 9,719 | -1,447 | 2,717 | 9 |
| 31 Dec 13 | 7,966 | -1,380 | 2,617 | 9 |
| 30 Sep 13 | 8,340 | -1,234 | 2,454 | 13 |
| 30 Jun 13 | 9,116 | -1,138 | 2,807 | 9 |
| 31 Mar 13 | 9,674 | -1,438 | 2,987 | 12 |
| 31 Dec 12 | 10,168 | -1,369 | 3,043 | 13 |
| 30 Sep 12 | 11,129 | 338 | 2,539 | 0 |
| 30 Jun 12 | 11,357 | 448 | 2,054 | 13 |
Quality Earnings: A101140 is currently unprofitable.
Growing Profit Margin: A101140 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A101140 is unprofitable, and losses have increased over the past 5 years at a rate of 41.4% per year.
Accelerating Growth: Unable to compare A101140's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A101140 is unprofitable, making it difficult to compare its past year earnings growth to the Luxury industry (-22.1%).
Return on Equity
High ROE: A101140 has a negative Return on Equity (-41.08%), as it is currently unprofitable.